Search

Aniket S Wadajkar

from Germantown, MD
Age ~42
Get Report
Also known as:
R E
Phone and address:
18811 Sparkling Water Dr APT T2, Germantown, MD 20874
Connected to:
Elvira G Wadas, 83Emily E Wadase, 32Catherine S Wadatz, 93Jessica Wadatz, 40Mussa A Waday, 94Harwinder K Wadbhage, 41Joyce M Wadbrook, 64Ndey S Wadda, 30Norman D Wadda, 58Bek K Waddah, 61

Aniket Wadajkar Phones & Addresses

  • 18811 Sparkling Water Dr APT T2, Germantown, MD 20874
  • Ellicott City, MD
  • Port Jefferson, NY
  • Stony Brook, NY
  • Arlington, TX
  • Saint Peters, MO

Work

Company: Applied dna sciences Oct 2012 Address: Stony Brook, NY Position: Scientist

Education

Degree: Ph.D. School / High School: The University of Texas at Arlington 2009 to 2012 Specialities: Biomedical Engineering

Skills

Tissue Engineering • Drug Delivery • Biomedical Engineering • Microscopy • Cell Culture • Nanoparticles • Biomaterials • Fluorescence Microscopy • Protein Chemistry • Imagej • Characterization • Western Blotting • Dna • Elisa • Purification • Stem Cells • Confocal Microscopy • Sds Page • Immunohistochemistry • Flow Cytometry • Nanotechnology • Spectroscopy • Protein Purification • Glp • Mammalian Cell Culture • Gel Electrophoresis • Good Laboratory Practice

Languages

English • Hindi • Marathi

Ranks

Certificate: Educators In Training (Edit) Program

Industries

Research

Resumes

Resumes

Aniket Wadajkar Photo 1

Associate Director

View page
Location:
Baltimore, MD
Industry:
Research
Work:
Applied DNA Sciences - Stony Brook, NY since Oct 2012
Scientist
University of Texas at Arlington - Arlington, TX Aug 2009 - Sep 2012
Research Assistant & Lab Manager
Antibody Research Corporation - St. Charles, MO Aug 2008 - Jul 2009
Research Scientist
University of Texas at Arlington - Arlington, TX Aug 2006 - Jul 2008
Research/Teaching Assistant
University of Pune - Pune, India Jun 2005 - Jul 2006
Research Assistant
Education:
The University of Texas at Arlington 2009 - 2012
Ph.D., Biomedical Engineering The University of Texas at Arlington 2006 - 2008
M.S., Biomedical Engineering University of Pune 2000 - 2005
B.E., Instrumentation & Control Engineering
Skills:
Tissue Engineering
Drug Delivery
Biomedical Engineering
Microscopy
Cell Culture
Nanoparticles
Biomaterials
Fluorescence Microscopy
Protein Chemistry
Imagej
Characterization
Western Blotting
Dna
Elisa
Purification
Stem Cells
Confocal Microscopy
Sds Page
Immunohistochemistry
Flow Cytometry
Nanotechnology
Spectroscopy
Protein Purification
Glp
Mammalian Cell Culture
Gel Electrophoresis
Good Laboratory Practice
Languages:
English
Hindi
Marathi
Certifications:
Educators In Training (Edit) Program

Publications

Us Patents

Decreased Adhesivity Receptor-Targeted Nanoparticles For Fn14-Positive Tumors

View page
US Patent:
20190328677, Oct 31, 2019
Filed:
Feb 28, 2019
Appl. No.:
16/289424
Inventors:
- Baltimore MD, US
Graeme F. Woodworth - Baltimore MD, US
Jeffrey A. Winkles - Frederick MD, US
Aniket Wadajkar - Germantown MD, US
International Classification:
A61K 9/51
A61K 9/50
C07K 16/28
A61K 47/69
A61P 35/00
A61K 31/337
A61K 47/68
A61K 47/60
Abstract:
Metastatic triple negative breast cancer (TNBC) still carries a dismal prognosis with the current treatment paradigms. The effectiveness of drug treatment for many solid tumors such as TNBC is limited by tumor heterogeneity, lack of tumor specificity, off-target toxicities, and transient therapeutic action(s). Strategies that provide tumor-specific, sustained concentrations of drugs to the tumors and tumor receptor-specific binding, while reducing off-target effects are needed to ensure sufficient tumor cell uptake within the primary and metastatic tumor microenvironment. The decreased non-specific adhesivity, receptor-targeted nanoparticle formulations (“DART” nanoparticles) of the invention were assessed for clinical potential in directing biological agents to the cell surface receptor Fn14, which is expressed in many solid cancer types, including TNBC primary tumors and metastatic lesions. They are contemplated for use against solid tumors, particularly brain tumors such as glioblastoma and breast cancer, including metastatic breast cancer.
Control profile
Aniket S Wadajkar from Germantown, MD, age ~42 Get Report